It is shown that cancer-associated DICER1 mutations shift microRNA processing and reactivate HERVH endogenous retroviruses and cause upregulation of transposable elements, including the human endogenous retrovirus H through miRNA-independent mechanisms.
Abstract
The DICER1 gene is mutated in cancer, including in DICER1-related tumour predisposition. Cancer-associated hotspot mutations have been reported in both catalytic domains of DICER and are predicted to disrupt miRNA biogenesis. To understand how these hotspot mutations contribute to cancer development, we generate cell lines harbouring single amino acid substitutions within the catalytic RNase IIIa (S1344L) or RNase IIIb (D1709N) domains of the endogenous DICER1 gene. Here we show that both mutations result in a widespread loss of 5p miRNAs, and an increase in 3p passenger strands loading into AGO2. The shared similarities between both mutants can be attributed to the structural proximity of the S1344 residue to the RNase IIIb catalytic centre. Functionally, we find that changes in the repertoire of miRNAs loaded into AGO2 result in altered gene expression, impacting critical pathways for cancer development. Additionally, our results indicate that inactivating the processing activity of DICER does not result in genomic instability. Instead, mutations cause upregulation of transposable elements, including the human endogenous retrovirus H through miRNA-independent mechanisms. This suggests that both canonical and non-canonical DICER functions are important to understand DICER1-related tumour predisposition. DICER1 is often mutated in cancer, including in DICER1-related tumour predisposition. Here, the authors show that cancer-associated DICER1 mutations shift microRNA processing and reactivate HERVH endogenous retroviruses.
AIMS
DICER1 is a microRNA biogenesis enzyme that, when mutated, results in a rewiring of the transcriptome. Germline pathogenic variants (PVs) in DICER1 result in DICER1-related tumour predisposition (DRTP) characterized by 30 or more different, generally rare, paediatric or adolescent-onset tumours. One of these, pitu...
P. Thorner, Anne-Laure Chong, Naciba Benlimane et al.· Histopathology· 0 citations
RCBTB2 (RCC1 and BTB domain-containing protein 2), located at chromosome 13q14, is affected by deletion, amplification, expression change, or gene fusion across the cancers studied to date. The divergent directions of these alterations do not fit a tumor-suppressor model with a fixed direction of action. Here, genetic,...
Chuanhai Cai, Jianjun Du, Li-Ga Tu et al.· Frontiers in Oncology· 0 citations
Understanding of the molecular mechanisms by which DNMT3A PWWP-domain mutations are mechanistically heterogeneous is advanced, providing a biochemical framework that contributes to distinct disease phenotypes.
A mechanism wherein SChLAP1 modulates AR signaling to promote PCa growth and progression is suggested, suggesting its molecular mechanism and potential to be used as a therapeutic target or biomarker.
Zoe Coutu, Srinivas Somarowthu· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.